Altimmune Inc (ALT)

SG&A Expenses

$7.57M

Quarterly · Period ending: · USD

ALT logo

ALT SG&A Expenses

Latest reported$7.57M
ALT Quarterly SG&A Expenses ($49.79K → $7.57M)
High-resolution chart · PNG

ALT sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Altimmune Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
7,574,000
8,052,000
10,510,000
5,904,000
5,691,000
5,993,000
5,090,000
4,969,000
5,595,000
5,312,000
4,332,000
4,514,000
4,760,000
4,531,000
3,805,000
4,492,000
4,410,000
4,427,000
3,777,000
4,155,999
3,659,000
3,821,000
4,111,929
4,220,238
2,545,356
2,331,917
2,014,822
2,187,661
2,231,817
2,066,482
2,419,930
1,963,733
2,933,982
2,447,894
1,593,775
3,038,756
1,794,509
3,228,590
5,171,645
3,714,747
1,435,381
1,193,298
975,789
1,231,035
1,819,241
2,196,120
2,621,936
3,192,427
2,419,909
2,677,452
4,580,313
4,086,348
2,332,730
2,279,795
2,624,724
3,275,428
2,780,099
2,948,481
2,678,807
3,283,246
3,409,372
4,939,654
5,390,629
3,177,888
4,121,822
5,325,422
6,645,470
6,224,868
4,416,248
5,146,000
4,741,561
4,803,190
5,174,056
4,678,723
5,276,876
3,150,894
0
92,228
159,260
102,651
101,075
126,405
93,494
49,785
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.